1959
DOI: 10.3109/00365515909060466
|View full text |Cite
|
Sign up to set email alerts
|

The Renal Extraction OF Para-Aminohippurate in Normal Persons and in Patients with Diseased Kidneys

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

5
15
1
1

Year Published

1964
1964
2006
2006

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(22 citation statements)
references
References 2 publications
5
15
1
1
Order By: Relevance
“…In the case of healthy controls, EpAH was assumed to be 0.85 (1 1). However, Epm has been shown to be moderately depressed in patients with proteinuric glomerular diseases, particularly when GFR is reduced (12)(13)(14)(15). To define a representative value of Epm in nephrotic subjects with membranous glomerulopathy, we determined this quantity directly on a separate occasion in four members of the experimental group.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…In the case of healthy controls, EpAH was assumed to be 0.85 (1 1). However, Epm has been shown to be moderately depressed in patients with proteinuric glomerular diseases, particularly when GFR is reduced (12)(13)(14)(15). To define a representative value of Epm in nephrotic subjects with membranous glomerulopathy, we determined this quantity directly on a separate occasion in four members of the experimental group.…”
Section: Methodsmentioning
confidence: 99%
“…In each case a relapse of the underlying glomerulopathy with reappearance of massive proteinuria became manifest within the 12-mo period preceding the study. 14 patients had received one or more receiving prednisone (range 7.5-90 mg daily), which in two cases was combined with azathioprine (1.5-2.0 mg/kg. d).…”
Section: Methodsmentioning
confidence: 99%
“…Previous estimations of renal circulatory function (ERPF) in such patients have been based on para-aminohippurate (PAH) clearance alone (3,9,10), which may correlate poorly with renal plasma flow when renal function is severely impaired (12). In addition, the pathophysiologic mechanisms that may reduce renal hemodynamic function in hepatic disease have not been investigated comprehensively.…”
mentioning
confidence: 99%
“…E PAH concentration, on the other hand, has frequently been reported to be depressed in the presence of chronic renal disease. [4][5][6][7][8] Consequently, C PAH is likely to underestimate renal plasma flow under these circumstances. Despite these limitations, however, the current clinical gold standard for measuring renal blood flow is based on determination of the C PAH .…”
Section: Introductionmentioning
confidence: 97%